Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 72.39%480.39M | ---- | 87.48%278.66M | ---- | 183.05%148.64M | ---- | 131.54%52.51M | ---- | -187.22%-166.5M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 7.76%-7.52M | ---- | 47.74%-8.15M | ---- | -13.63%-15.59M | ---- | -32.53%-13.72M | ---- | 33.71%-10.35M |
| Attributable subsidiary (profit) loss | ---- | -37.05%-11.75M | ---- | 83.21%-8.57M | ---- | -342.50%-51.07M | ---- | 53.27%-11.54M | ---- | 45.57%-24.7M |
| Impairment and provisions: | ---- | 112.97%141.08M | ---- | 57.45%66.25M | ---- | 472.99%42.08M | ---- | -94.19%7.34M | ---- | 105.93%126.32M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.5M |
| -Other impairments and provisions | ---- | 112.97%141.08M | ---- | 57.45%66.25M | ---- | 472.99%42.08M | ---- | -93.77%7.34M | ---- | 172.31%117.81M |
| Revaluation surplus: | ---- | 44.93%42.23M | ---- | 105.52%29.14M | ---- | -33.41%14.18M | ---- | -23.62%21.29M | ---- | 424.68%27.88M |
| -Fair value of investment properties (increase) | ---- | 44.93%42.23M | ---- | 105.52%29.14M | ---- | -33.41%14.18M | ---- | -23.62%21.29M | ---- | 424.68%27.88M |
| Asset sale loss (gain): | ---- | -148.36%-59K | ---- | -65.73%122K | ---- | -78.50%356K | ---- | 50.41%1.66M | ---- | 76.73%1.1M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | -99.18%19K | ---- | --2.31M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -148.36%-59K | ---- | -63.80%122K | ---- | 151.61%337K | ---- | -161.14%-653K | ---- | 198.43%1.07M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.07%33K |
| Depreciation and amortization: | ---- | -18.00%63.81M | ---- | 9.34%77.82M | ---- | -0.53%71.17M | ---- | 9.92%71.55M | ---- | 39.19%65.09M |
| -Amortization of intangible assets | ---- | 18.55%18.04M | ---- | 8.25%15.22M | ---- | 6.33%14.06M | ---- | 7.72%13.22M | ---- | 743.37%12.27M |
| Financial expense | ---- | 45.39%9.26M | ---- | 87.37%6.37M | ---- | 128.67%3.4M | ---- | -26.54%1.49M | ---- | 242.30%2.02M |
| Special items | ---- | -12.11%-54.9M | ---- | 32.34%-48.97M | ---- | -125.08%-72.38M | ---- | 41.41%-32.16M | ---- | -2,123.13%-54.89M |
| Operating profit before the change of operating capital | ---- | 68.73%662.55M | ---- | 178.92%392.66M | ---- | 43.04%140.78M | ---- | 389.19%98.42M | ---- | -114.92%-34.03M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -25.19%-1.32M | ---- | -184.01%-1.06M | ---- | 293.38%1.26M | ---- | -118.86%-650K | ---- | -102.56%-297K |
| Accounts receivable (increase)decrease | ---- | -195.72%-1.9B | ---- | -21.68%-641.68M | ---- | -61.99%-527.35M | ---- | -699.84%-325.54M | ---- | 210.45%54.27M |
| Accounts payable increase (decrease) | ---- | 115.06%1.62B | ---- | 14.10%753.72M | ---- | 361.25%660.6M | ---- | 196.28%143.22M | ---- | -304.64%-148.76M |
| prepayments (increase)decrease | ---- | 66.46%-60.28M | ---- | -136.91%-179.74M | ---- | 10.38%-75.87M | ---- | -974.83%-84.65M | ---- | -57.21%-7.88M |
| Special items for working capital changes | ---- | -614.54%-539.82M | ---- | -1,380.04%-75.55M | ---- | -97.77%5.9M | ---- | 15.34%264.84M | ---- | 7,302.39%229.62M |
| Cash from business operations | ---- | -186.76%-215.48M | ---- | 20.96%248.36M | ---- | 114.70%205.32M | ---- | 2.91%95.63M | ---- | -64.45%92.93M |
| Other taxs | ---- | -92.88%-16.01M | ---- | 53.22%-8.3M | ---- | -135.60%-17.74M | ---- | 14.85%-7.53M | ---- | -51.85%-8.84M |
| Special items of business | -18.70%-881.04M | ---- | -26.02%-742.25M | ---- | -724.56%-588.99M | ---- | -45.11%-71.43M | ---- | 70.00%-49.22M | ---- |
| Net cash from operations | -18.70%-881.04M | -196.43%-231.48M | -26.02%-742.25M | 27.98%240.06M | -724.56%-588.99M | 112.91%187.58M | -45.11%-71.43M | 4.78%88.1M | 70.00%-49.22M | -67.10%84.08M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -7.76%7.52M | ---- | -47.74%8.15M | ---- | 13.63%15.59M | ---- | 32.53%13.72M | ---- | -33.71%10.35M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | -95.22%3.7M | ---- | -37.08%77.42M | ---- | 42.22%123.04M |
| Loan receivable (increase) decrease | ---- | 172.75%26.8M | ---- | -854.30%-36.84M | ---- | 43.78%-3.86M | ---- | -829.09%-6.87M | ---- | 32.14%-739K |
| Decrease in deposits (increase) | ---- | -1,974.12%-67.64M | ---- | -425.45%-3.26M | ---- | 108.88%1M | ---- | -679.56%-11.29M | ---- | -144.13%-1.45M |
| Sale of fixed assets | ---- | -95.44%678K | ---- | 1,494.85%14.86M | ---- | -46.56%932K | ---- | -76.17%1.74M | ---- | 3.19%7.32M |
| Purchase of fixed assets | ---- | 53.87%-12.37M | ---- | 15.75%-26.81M | ---- | 15.27%-31.83M | ---- | -129.06%-37.56M | ---- | 10.55%-16.4M |
| Purchase of intangible assets | ---- | -286.96%-57.44M | ---- | -206.04%-14.84M | ---- | ---4.85M | ---- | ---- | ---- | 70.57%-12.53M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -28.81%25.44M | ---- | --35.74M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---3.24M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 99.55%-1M | ---- | ---220M | ---- | ---- | ---- | ---- | ---- | 97.02%-6.66M |
| Other items in the investment business | -1,594.27%-70.41M | ---- | 98.14%-4.16M | ---- | -956.61%-222.91M | ---- | -129.80%-21.1M | --16.97M | 198.39%70.81M | ---- |
| Net cash from investment operations | -1,594.27%-70.41M | 62.89%-103.45M | 98.14%-4.16M | -9,731.69%-278.74M | -956.61%-222.91M | -96.78%2.89M | -129.80%-21.1M | -12.68%89.88M | 198.39%70.81M | 177.40%102.93M |
| Net cash before financing | -27.47%-951.45M | -765.79%-334.93M | 8.07%-746.41M | -120.31%-38.69M | -777.47%-811.9M | 7.02%190.47M | -528.75%-92.53M | -4.83%177.98M | 109.14%21.58M | 52.52%187.02M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 66.77%505.27M | ---- | --302.97M | ---- | ---- | ---- | ---- | ---- | ---- |
| Refund | ---- | -259.34%-514.07M | ---- | -6.82%-143.06M | ---- | -7,659.62%-133.93M | ---- | -3,096.30%-1.73M | ---- | 99.23%-54K |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.13M | ---- | ---- |
| Interest paid - financing | ---- | -53.39%-6.13M | ---- | -17.51%-3.99M | ---- | -128.67%-3.4M | ---- | 26.54%-1.49M | ---- | -242.30%-2.02M |
| Dividends paid - financing | ---- | -52.08%-31.25M | ---- | ---20.55M | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | 3,495.61%35.24M | ---- | -44.94%980K | ---- | --1.78M | ---- | ---- | ---- | -87.05%3.41M |
| Other items of the financing business | 8,298.13%900.45M | -31.64%4.39M | -89.03%10.72M | -95.03%6.42M | --97.74M | 4,075.50%129.36M | ---- | 7.91%3.1M | ---- | 102.16%2.87M |
| Net cash from financing operations | 8,298.13%900.45M | -123.70%-26.28M | -89.03%10.72M | 495.37%110.85M | --97.74M | -126.60%-28.04M | ---- | -5.94%-12.37M | ---- | 93.01%-11.68M |
| Effect of rate | 1,895.69%2.08M | 714.80%5.11M | -250.65%-116K | 65.42%-831K | 11.59%77K | 30.77%-2.4M | -99.68%69K | -106.78%-3.47M | 254.21%21.75M | 476.88%51.21M |
| Net Cash | 93.07%-51.01M | -600.53%-361.21M | -3.01%-735.68M | -55.57%72.17M | -671.84%-714.17M | -1.92%162.43M | -528.75%-92.53M | -5.55%165.61M | 109.15%21.58M | 494.30%175.34M |
| Begining period cash | -28.16%908.41M | 5.98%1.26B | 5.98%1.26B | 15.49%1.19B | 15.49%1.19B | 18.62%1.03B | -0.05%1.03B | 7.91%871M | 28.07%1.03B | -6.71%807.13M |
| Cash at the end | 62.56%859.48M | -28.16%908.41M | 10.36%528.7M | 5.98%1.26B | -49.07%479.08M | 15.49%1.19B | -12.66%940.68M | -0.05%1.03B | 93.26%1.08B | 28.07%1.03B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Deloitte Touche Tohmatsu | -- | Deloitte Touche Tohmatsu | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.